Centre for Health, Exercise and Sports Medicine, Department of Physiotherapy, University of Melbourne, Parkville, 3010 VIC, Australia.
BMJ. 2011 May 18;342:d2912. doi: 10.1136/bmj.d2912.
To assess the effect of lateral wedge insoles compared with flat control insoles on improving symptoms and slowing structural disease progression in medial knee osteoarthritis.
Randomised controlled trial.
Community in Melbourne, Australia.
200 people aged 50 or more with clinical and radiographic diagnosis of mild to moderately severe medial knee osteoarthritis.
Full length 5 degree lateral wedged insoles or flat control insoles worn inside the shoes daily for 12 months.
Primary symptomatic outcome was change in overall knee pain (past week) measured on an 11 point numerical rating scale. Primary structural outcome was change in volume of medial tibial cartilage from magnetic resonance imaging scans. Secondary clinical outcomes included changes in measures of pain, function, stiffness, and health related quality of life. Secondary structural outcomes included progression of medial cartilage defects and bone marrow lesions.
Between group differences did not differ significantly for the primary outcomes of change in overall pain (-0.3 points, 95% confidence intervals -1.0 to 0.3) and change in medial tibial cartilage volume (-0.4 mm(3), 95% confidence interval -15.4 to 14.6), and confidence intervals did not include minimal clinically important differences. None of the changes in secondary outcomes showed differences between groups.
Lateral wedge insoles worn for 12 months provided no symptomatic or structural benefits compared with flat control insoles. Trial registration Australian New Zealand Clinical Trials Registry ACTR12605000503628 and ClinicalTrials.gov NCT00415259.
评估外侧楔形鞋垫与平底对照鞋垫相比,在改善内侧膝关节骨关节炎症状和减缓结构疾病进展方面的效果。
随机对照试验。
澳大利亚墨尔本社区。
200 名年龄在 50 岁及以上、有临床和影像学诊断的轻度至中度严重内侧膝关节骨关节炎的患者。
全长 5 度外侧楔形鞋垫或平底对照鞋垫,每天穿在鞋内 12 个月。
主要症状结局是通过 11 点数字评分量表测量的整体膝关节疼痛(过去一周)的变化。主要结构结局是通过磁共振成像扫描测量内侧胫骨软骨体积的变化。次要临床结局包括疼痛、功能、僵硬和健康相关生活质量的变化。次要结构结局包括内侧软骨缺损和骨髓病变的进展。
组间差异在主要结局(总体疼痛变化-0.3 分,95%置信区间-1.0 至 0.3)和内侧胫骨软骨体积变化(-0.4 毫米 3,95%置信区间-15.4 至 14.6)方面无显著差异,置信区间不包括最小临床重要差异。次要结局的任何变化均未显示组间差异。
与平底对照鞋垫相比,佩戴 12 个月的外侧楔形鞋垫在症状或结构方面没有益处。试验注册澳大利亚新西兰临床试验注册中心 ACTR12605000503628 和 ClinicalTrials.gov NCT00415259。